• BlueFuture Aquatics filed an amended 8-K to correct and update disclosures tied to its March 17, 2026 IP deal with Hydrenesis.
• The filing confirms the contemplated IP transfer did not occur; Hydrenesis instead granted a perpetual, worldwide, exclusive, sublicensable aquaculture license effective June 25, 2026.
• Preferred stock consideration was revised: Series P for CEO David Antelo at 10% economic ownership, Series P-2 for Hydrenesis at 15%, on a fully diluted basis.
• Milestone-based preferred shares could lift combined Antelo-Hydrenesis economic ownership to 65% if targets are met.
• The amendment also corrects the registrant’s legal name to BlueFuture Aquatics, reflecting a February 11, 2026 name change.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bluefuture Aquatics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-034166), on July 22, 2026, and is solely responsible for the information contained therein.